Streamline Health Solutions, Inc.
STRM
$3.19
$0.0692.21%
Weiss Ratings | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.29 | |||
Price History | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -8.89% | |||
30-Day Total Return | -20.28% | |||
60-Day Total Return | -1.27% | |||
90-Day Total Return | 59.45% | |||
Year to Date Total Return | -12.87% | |||
1-Year Total Return | -56.61% | |||
2-Year Total Return | -89.10% | |||
3-Year Total Return | -84.48% | |||
5-Year Total Return | -80.85% | |||
52-Week High % Change | -67.99% | |||
52-Week Low % Change | 68.65% | |||
Price | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $9.75 | |||
52-Week Low Price | $1.85 | |||
52-Week Low Price (Date) | Oct 28, 2024 | |||
52-Week High Price (Date) | Jun 11, 2024 | |||
Valuation | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 12.64M | |||
Enterprise Value | 24.15M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.38 | |||
Earnings Per Share Growth | -54.21% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.68 | |||
Price/Book (Q) | 0.96 | |||
Enterprise Value/Revenue (TTM) | 1.30 | |||
Price | $3.19 | |||
Enterprise Value/EBITDA (TTM) | -8.36 | |||
Enterprise Value/EBIT | -3.20 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 4.06M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 888 997 8732 | |||
Address | 2400 Old Milton Pkwy Alpharetta, GA 30009 | |||
Website | www.streamlinehealth.net | |||
Country | United States | |||
Year Founded | 1989 | |||
Profitability | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -40.62% | |||
Profit Margin | -50.51% | |||
Management Effectiveness | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -12.25% | |||
Return on Equity | -- | |||
Income Statement | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 18.59M | |||
Total Revenue (TTM) | 18.59M | |||
Revenue Per Share | $4.58 | |||
Gross Profit (TTM) | 9.10M | |||
EBITDA (TTM) | -2.89M | |||
EBIT (TTM) | -7.55M | |||
Net Income (TTM) | -9.39M | |||
Net Income Avl. to Common (TTM) | -9.39M | |||
Total Revenue Growth (Q YOY) | -27.95% | |||
Earnings Growth (Q YOY) | 79.21% | |||
EPS Diluted (TTM) | -2.38 | |||
EPS Diluted Growth (Q YOY) | 80.62% | |||
Balance Sheet | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 754.00K | |||
Cash Per Share (Q) | $0.19 | |||
Total Current Assets (Q) | 5.39M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 13.91M | |||
Current Ratio (Q) | 0.455 | |||
Book Value Per Share (Q) | $3.26 | |||
Total Assets (Q) | 35.97M | |||
Total Current Liabilities (Q) | 11.85M | |||
Total Debt (Q) | 12.26M | |||
Total Liabilities (Q) | 22.05M | |||
Total Common Equity (Q) | 13.91M | |||
Cash Flow | STRM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -679.00K | |||
Cash from Financing (TTM) | 1.57M | |||
Net Change in Cash (TTM) | -1.80M | |||
Levered Free Cash Flow (TTM) | -1.19M | |||
Cash from Operations (TTM) | -2.69M | |||